176 related articles for article (PubMed ID: 24918866)
1. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer.
He L; Wu L; Su G; Wei W; Liang L; Han L; Kebria M; Liu P; Chen C; Yu Y; Zhong M; Wang W
Gynecol Oncol; 2014 Aug; 134(2):419-25. PubMed ID: 24918866
[TBL] [Abstract][Full Text] [Related]
2. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria.
Hu T; Li S; Chen Y; Shen J; Li X; Huang K; Yang R; Wu L; Chen Z; Jia Y; Wang S; Cheng X; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Xu H; Xu J; Zhang Q; Xi L; Deng D; Wang H; Wang S; Lv W; Wang C; Xie X; Ma D
Eur J Cancer; 2012 Oct; 48(15):2353-60. PubMed ID: 22503395
[TBL] [Abstract][Full Text] [Related]
3. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
[TBL] [Abstract][Full Text] [Related]
4. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.
Kim HS; Sardi JE; Katsumata N; Ryu HS; Nam JH; Chung HH; Park NH; Song YS; Behtash N; Kamura T; Cai HB; Kim JW
Eur J Surg Oncol; 2013 Feb; 39(2):115-24. PubMed ID: 23084091
[TBL] [Abstract][Full Text] [Related]
6. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
Hu Y; Han Y; Shen Y; Chen J; Chen Y; Chen Y; Tang J; Xue M; Hong L; Cheng W; Wang D; Liang Z; Wang Y; Zhang Q; Xing H; Zhang Y; Yi C; Yu Z; Chen Y; Cui M; Ma C; Yang H; Li R; Long P; Zhao Y; Qu P; Tao G; Yang L; Wu S; Liu Z; Yang P; Lv W; Xie X; Ma D; Wang H; Li K
BMC Cancer; 2022 Dec; 22(1):1270. PubMed ID: 36471257
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy.
Wang PH; Chang YH; Yang YH; Chang WH; Huang SY; Lai CR; Juang CM; Chen YJ; Horng HC; Wen KC; Ng HT; Yuan CC; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):330-6. PubMed ID: 25286786
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
Lee J; Kim TH; Kim GE; Keum KC; Kim YB
J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
[TBL] [Abstract][Full Text] [Related]
10. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y; Zhang G; Li Z; Chen B; Zhao H; Yang Y; Wang L; Yao J; Chen X; Huang Y; Lang J; Liu P; Chen C
Cancer Med; 2023 Oct; 12(19):19617-19632. PubMed ID: 37768092
[TBL] [Abstract][Full Text] [Related]
11. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
[No Abstract] [Full Text] [Related]
13. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
Xu Y; Zhang M; Zhang J; Ng DM; Chen X; Si Y; Shi Y; Li X; Mao D; Yang L
Taiwan J Obstet Gynecol; 2021 May; 60(3):433-441. PubMed ID: 33966724
[TBL] [Abstract][Full Text] [Related]
16. Locally advanced cervical adenocarcinoma: is there a place for chemo-surgical treatment?
Benedetti-Panici P; Greggi S; Scambia G; Salerno MG; Amoroso M; Maneschi F; Cutillo G; Caruso A; Capelli A; Mancuso S
Gynecol Oncol; 1996 Apr; 61(1):44-9. PubMed ID: 8626116
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
20. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
